COAs and DHTs – measure what matters
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Oncology treatments tailored specifically for young adults.
Cassandra offers up to 99% accuracy predicting the need for PMRs.
Uncover how reshaping data and integration strategies can empower your organisation.
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
10 September 2024
11 September 2024
ICON Cares is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
